Study Evaluating Alectinib Pharmacokinetics in the Hispanic Population With Advanced ALK-Rearranged Non-small-Cell Lung Cancer

被引：0
|
作者：
Arrieta, Oscar [1 ]
Lara-Mejia, Luis [1 ]
Garcia Lopez, Patricia [2 ]
Hernandez-Pedro, Norma [3 ,4 ]
Cruz-Rico, Graciela [1 ]
Heredia, David [1 ]
Sanchez-Reyes, Roberto [1 ]
Infante-Gonzalez, Cesar [1 ]
Martinez Perez, Aida
Matias-Cruz, Venecia [1 ]
Lopez Samchez, Denise [1 ]
Cardona, Andres [5 ]
机构：
[1] Inst Nacl Cancerol, Thorac Oncol Dept, Thorac Oncol Unit, Mexico City, DF, Mexico
[2] Inst Nacl Cancerol, Lab Farmacol, Subdirecc Invest Basica, Mexico City, DF, Mexico
[3] Inst Nacl Cancerol, Thorac Oncol Unit, Mexico City, DF, Mexico
[4] Inst Nacl Cancerol, Lab Personalized Med, Mexico City, DF, Mexico
[5] Clin Country, Clin & Traslat Oncol Grp, Bogota, Colombia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP.01
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [1] The role of alectinib in the treatment of advanced ALK-rearranged non-small-cell lung cancer
    Srinivasamaharaj, Srividya
    Salame, Bilal Khameze
    Rios-Perez, Jorge
    Kloecker, Goetz
    Perez, Cesar A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (12) : 1227 - 1233
  • [2] Treatment modalities for advanced ALK-rearranged non-small-cell lung cancer
    Sullivan, Ivana
    Planchard, David
    FUTURE ONCOLOGY, 2016, 12 (07) : 945 - 961
  • [3] Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
    Shaw, Alice T.
    Kim, Dong-Wan
    Mehra, Ranee
    Tan, Daniel S. W.
    Felip, Enriqueta
    Chow, Laura Q. M.
    Camidge, D. Ross
    Vansteenkiste, Johan
    Sharma, Sunil
    De Pas, Tommaso
    Riely, Gregory J.
    Solomon, Benjamin J.
    Wolf, Juergen
    Thomas, Michael
    Schuler, Martin
    Liu, Geoffrey
    Santoro, Armando
    Lau, Yvonne Y.
    Goldwasser, Meredith
    Boral, Anthony L.
    Engelman, Jeffrey A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (13): : 1189 - 1197
  • [4] Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
    Shen, Liang
    Ji, Hong-Fang
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (26): : 2537 - 2537
  • [5] Tumor Volume Nadir in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Treated With Alectinib
    Nishino, Mizuki
    Wei, Zihan
    Mazzola, Emanuele
    Hino, Takuya
    Tseng, Shu-Chi
    Sanchez, Michelle E.
    Hatabu, Hiroto
    Johnson, Bruce E.
    Awad, Mark M.
    JCO PRECISION ONCOLOGY, 2023, 7
  • [6] Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    Kate McKeage
    Drugs, 2015, 75 : 75 - 82
  • [7] Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    McKeage, Kate
    DRUGS, 2015, 75 (01) : 75 - 82
  • [8] Alectinib: a selective, next-generation ALK inhibitor for treatment of ALK-rearranged non-small-cell lung cancer
    Santarpia, Mariacarmela
    Altavilla, Giuseppe
    Rosell, Rafael
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (03) : 255 - 268
  • [9] Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study
    Ou, Sai-Hong Ignatius
    Ahn, Jin Seok
    De Petris, Luigi
    Govindan, Ramaswamy
    Yang, James Chih-Hsin
    Hughes, Brett
    Lena, Herve
    Moro-Sibilot, Denis
    Bearz, Alessandra
    Ramirez, Santiago Viteri
    Mekhail, Tarek
    Spira, Alexander
    Bordogna, Walter
    Balas, Bogdana
    Morcos, Peter N.
    Monnet, Annabelle
    Zeaiter, Ali
    Kim, Dong-Wan
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07) : 661 - +
  • [10] Targeting ALK-rearranged non-small-cell lung cancer: an update
    Sullivan, Ivana
    Planchard, David
    FUTURE ONCOLOGY, 2017, 13 (14) : 1213 - 1217
12345